CABOSEQ 3-Comparison of Cabozantinib versus Sunitinib Following First-Line Nivolumab- Ipilimumab for Metastatic Renal Cell Carcinoma: A Target Trial Emulation Using Real-World Data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). - Lemelin A; Maj D; Takemura K; Boyne DJ; Warkentin MT; Brenner DR; Cheung WY; Wells C; Labaki C; McGregor BA; Contreras LM; Pal SK; et al. (Clinical genitourinary cancer, 2025)